Prognia
Drug Database
🇪🇺EU · EMAOpinionATC: A10BJ02

Ablymico(liraglutide)

Obesity;Overweight

Marketing Authorisation Holder: STADA Arzneimittel AG

INN: liraglutide

Indication

Treatment of weight management.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ablymico — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.